Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages
暂无分享,去创建一个
G. Aust | O. Uckermann | K. Spanel‐Borowski | S. Löffler | E. Brylla | Maren Geyer | K. Spanel‐borowski | Ortrud Uckermann
[1] P. Huber,et al. Cytokeratin expression in bovine corpora lutea , 1995, Histochemistry and Cell Biology.
[2] K. Spanel‐Borowski,et al. Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application , 2004, Regulatory Peptides.
[3] S. Hunt,et al. Increased formation of corpora lutea in neurokinin 1‐receptor deficient mice , 2004, Molecular reproduction and development.
[4] B. Rueda,et al. Microvascular endothelial cells of the corpus luteum , 2003, Reproductive biology and endocrinology : RB&E.
[5] K. Spanel‐Borowski,et al. Pregnancy-induced changes in substance P and neurokinin 1 receptor (NK1-R) expression in the rat uterus. , 2003, Reproduction.
[6] M. Candenas,et al. A Role for Tachykinins in Female Mouse and Rat Reproductive Function1 , 2003, Biology of reproduction.
[7] H. Minakata,et al. Insight into Tachykinin-Related Peptides, Their Receptors, and Invertebrate Tachykinins: A review , 2003, Zoological science.
[8] S. Gardiner,et al. Characterization of the endokinins: Human tachykinins with cardiovascular activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] G. Hamlin,et al. Estrogen-Dependent Regulation of Neurokinin 3 Receptor-Mediated Uterine Contractility in the Rat1 , 2002, Biology of reproduction.
[10] S. Böckmann. Substance P (NK1) receptor expression by human colonic epithelial cell line Caco-2 , 2002, Peptides.
[11] M. Brännström,et al. Leukocyte networks and ovulation. , 2002, Journal of reproductive immunology.
[12] C. Austin,et al. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. , 2002, Gene.
[13] P. Nieto,et al. Changes in the Expression of Tachykinin Receptors in the Rat Uterus During the Course of Pregnancy1 , 2001, Biology of reproduction.
[14] P. Lowry,et al. A regulatory role for neurokinin B in placental physiology and pre-eclampsia , 2001, Regulatory Peptides.
[15] G. Aust,et al. The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage , 2001, Neuroscience Letters.
[16] EN Patak,et al. Effects Of Tachykinins On Uterine Smooth Muscle , 2000, Clinical and experimental pharmacology & physiology.
[17] Gillian E. Wu,et al. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis , 2000, Nature Immunology.
[18] C. Maggi,et al. Peripheral actions of tachykinins , 2000, Neuropeptides.
[19] J. Calixto,et al. Neurokinin mediation of edema and inflammation , 2000, Neuropeptides.
[20] C. Maggi. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system , 2000, Regulatory Peptides.
[21] S. Gardiner,et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia , 2000, Nature.
[22] G. Hamlin,et al. Hormonal Variation of Rat Uterine Contractile Responsiveness to Selective Neurokinin Receptor Agonists1 , 2000, Biology of reproduction.
[23] K. Spanel‐Borowski,et al. Difference in localization of eosinophils and mast cells in the bovine ovary , 2000 .
[24] P. Rameshwar,et al. Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] G. Aust,et al. Cloning of bovine RANTES mRNA and its expression and regulation in ovaries in the periovulatory period , 1999, FEBS letters.
[26] J. Olerud,et al. VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. , 1999, Journal of immunology.
[27] J. Olerud,et al. Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. , 1998, American journal of physiology. Cell physiology.
[28] W. Ho,et al. Human lymphocytes express substance P and its receptor , 1998, Journal of Neuroimmunology.
[29] K. Spanel‐Borowski,et al. Immunolocalization of CD18-positive cells in the bovine ovary. , 1997, Journal of reproduction and fertility.
[30] C. Maggi. The effects of tachykinins on inflammatory and immune cells , 1997, Regulatory Peptides.
[31] H. Sarau,et al. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework. , 1997, Journal of medicinal chemistry.
[32] K. Spanel‐Borowski,et al. Evidence for the maintenance of macrophage-like cells in long-term bovine granulosa cell cultures , 1997, Cell and Tissue Research.
[33] S. Fukuhara,et al. Further Identification of Neurokinin Receptor Types and Mechanisms of Calcium Signaling Evoked by Neurokinins in the Murine Neuroblastoma C1300 Cell Line , 1996, Journal of neurochemistry.
[34] W. Scherbaum,et al. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). , 1996, Thyroid : official journal of the American Thyroid Association.
[35] C. Wiedermann,et al. Induction of endothelial cell differentiation into capillary-like structures by substance P. , 1996, European journal of pharmacology.
[36] C. Maggi,et al. Tachykinin receptors and receptor subtypes. , 1995, Archives internationales de pharmacodynamie et de therapie.
[37] C. Murphy,et al. Growth-promoting effects of substance P on endothelial cells in vitro. Synergism with calcitonin gene-related peptide, insulin, and plasma factors. , 1994, Circulation research.
[38] D. Schams,et al. Multiple effects of neuropeptide Y, substance P and vasoactive intestinal polypeptide on progesterone and oxytocin release from bovine corpus luteum in vitro. , 1993, The Journal of endocrinology.
[39] C. Strader,et al. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. , 1992, Molecular pharmacology.
[40] R. A. Akhtar,et al. Species differences in the effects of substance P on inositol trisphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: differences in receptor density. , 1991, Experimental eye research.
[41] S. Nakanishi,et al. Molecular Characterization of the Three Tachykinin Receptors , 1991, Annals of the New York Academy of Sciences.
[42] F. Nantel,et al. Neurokinin Agonists and Antagonists , 1991, Annals of the New York Academy of Sciences.
[43] H. Jarry,et al. Effects of substance-P and neuropeptide-Y on in vitro steroid release by porcine granulosa and luteal cells. , 1991, Endocrinology.
[44] W. Schulze,et al. Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis. , 1991, Endocrinology.
[45] C. Maggi,et al. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. , 1990, Microvascular research.
[46] K. Spanel‐Borowski,et al. Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM). , 1990, Cell and tissue research.
[47] M. Moskowitz,et al. Identification of immunoreactive substance P in human and other mammalian endothelial cells , 1989, Peptides.
[48] R. Laufer,et al. [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype. , 1986, Journal of medicinal chemistry.
[49] E. Jaffe,et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.